raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:382

Guanidinoacetate methyltransferase deficiency

Synonyms: GAMT deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood, Infancy
Status
active

Guanidinoacetate methyltransferase (GAMT) deficiency is a creatine deficiency syndrome characterized by global developmental delay/intellectual disability (DD/ID), prominent speech delay, autistic/hyperactive behavioral disorders, seizures, and various types of pyramidal and/or extra-pyramidal manifestations.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enGuanidinoacetate methyltransferase deficiencyGAMT deficiency
frDéficit en guanidinoacétate méthyltransféraseDéficit en GAMT
deGuanidinoacetat-Methyltransferase-MangelGAMT-Mangel
esDeficiencia de guanidinoacetato metiltransferasaDeficiencia GAMT
itDeficit di guanidinoacetato metiltransferasiDeficit di GAMT
nlGuanidinoacetaat-methyltransferasedeficiëntieGAMT-deficiëntie
ptDeficiência de guanidinoacetato metiltransferaseDeficiência cerebral de creatina · Deficiência de GAMT
plDeficyt metylotransferazy kwasu guanidynooctowegoNiedobór GAMT
csDeficit guanidinoacetát methyltransferázyGAMT deficit
ukДефіцит гуанідиноацетатметилтрансферазиДефіцит GAMT
zh乙酸胍转甲基酶缺乏症乙酸胍转甲基酶缺乏症
trGuanidinoasetat metiltransferaz eksikliğiGAMT eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM612736Evalidated
ICD-10E72.8NTBTattributedvalidated
ICD-115C53.4NTBTindexvalidated
MONDO0012999Evalidated
MeSHC537622Evalidated
UMLSC0574080Evalidated
GARD2578Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
GAMTDisease-causing germline mutation(s) inAssessedHGNC:4136ENSG0000013000560124019p13.3guanidinoacetate N-methyltransferase20301745[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families80 casesWorldwideCase(s)Validated20301745[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

22 annotations · validated 2019-09-13
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0001250Seizure
Frequent (79-30%)
HP:0002071Abnormality of extrapyramidal motor function
HP:0100022Abnormality of movement
HP:0000708Atypical behavior
HP:0010864Intellectual disability, severe
HP:0002465Poor speech
HP:0007153Progressive extrapyramidal movement disorder
HP:0011344Severe global developmental delay
Occasional (29-5%)
HP:0002457Abnormal head movements
HP:0000718Aggressive behavior
HP:0001251Ataxia
HP:0002305Athetosis
HP:0010819Atonic seizure
HP:0000717Autism
HP:0002069Bilateral tonic-clonic seizure
HP:0002072Chorea
HP:0001332Dystonia
HP:0002384Focal impaired awareness seizure
HP:0002123Generalized myoclonic seizure
HP:0000752Hyperactivity
HP:0100716Self-injurious behavior
Very rare (<4-1%)
HP:0001252Hypotonia

Run the differential on the 1 obligate / very frequent terms

Annotation source: 78088440[PMID]_8651275[PMID]_9386672[PMID]_15651030[PMID]_20301745[PMID]

7

Sources for this card